What question did this study set out to answer?

The study aims to evaluate a novel nanotherapeutic for restoring mitochondrial metabolism and reducing inflammation in acute pancreatitis.

March 21, 2026ACS Nano

Hierarchically Targeted Cu-Doped Carbon Dot/Kynurenic Acid@RM Platform for Restoring Mitochondrial Metabolism and Modulating Inflammation in Acute Pancreatitis

View Full Paper

Ask AI

Bookmark

Authors

Nanotherapeutic RMCK improves mitochondrial function and reduces inflammation in acute pancreatitis, indicating a new treatment approach.

The study aims to evaluate a novel nanotherapeutic for restoring mitochondrial metabolism and reducing inflammation in acute pancreatitis.
Developed hierarchically targeted Cu-CDs/Kyna@RM nanotherapeutics.
Administered RMCK systemically to an acute pancreatitis model.
Conducted in vitro experiments to assess acinar cell injury and mitochondrial function.
Utilized transcriptomics and immunohistochemistry for mechanistic analysis.
RMCK significantly improves survival rates in acute pancreatitis models.
Reduces serum amylase and lipase levels, indicating improved pancreatic function.
Alleviates pancreatic edema and necrosis, and prevents secondary lung injury.
In vitro results show reduced acinar cell injury and LDH release.

Zhao et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark